← Back to headlines
J&J's Rybrevant Faspro Receives Monthly Dosing Approval
Johnson & Johnson has secured approval for monthly dosing of its drug Rybrevant Faspro, offering a new treatment option.
17 Feb, 14:18 — 17 Feb, 14:18
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Alzheimer's Warning Sign Often Mistaken for Character Flaw
15m ago
California Woman Hospitalized After Portable Charger Explodes in Bed
35m ago
Psychiatrist Advocates for Social Media Ban for Under-16s Citing Mental Health Concerns
35m ago
Kenya's Blackjack Weed Craze: Doctors Urge Caution Amid Herbalist Claims
1h ago